Medical training for the application of Heberprot P begins in Mongolia.

Ulaanbaatar, Mongolia. June 18, 2018. With the presence of Dr. Yanisbel Ortiz Peña, first degree specialist in Vascular Surgery of the National Diabetes Care Group of the Center for Genetic Engineering and Biotechnology (CIGB), training began in Ulaanbaatar today of the Mongolian medical specialists in the extensive use of the Cuban medicine Heberprot P for the treatment of diabetic foot ulcers. At the first meeting of the Diabetes Association of Mongolia, Dr. Ortiz presented the product and presented it to Mr. Kh. Altaisaikhan, Doctor of Sciences and President of said association the best practices and Cuban results in the use of this medicine.

The training extend for two weeks and will include master classes and practical events in the application and treatment of diabetic foot ulcers in Mongolian patients affected with this disease and will include the presence of endocrinologists, angiologists and other medical specialists from some public hospitals in Mongolia. Dr. Ortiz will also hold meetings with doctors and managers of hospitals in other provinces outside the capital with the aim of creating the conditions for the proper use and extensive use in Mongolia of the novel and world-renowned Cuban medicine.

The session was also attended by Dr. Sonomtseren Sainbileg, Doctor of Science and responsible for the ENDOMED Clinic specializing in the care of diabetic patients and their complications. The Cuban medicine was registered in Mongolia last May by the pharmaceutical company MEIC (Mongolia Export / Import Concert) who signed in 2017 a contract with the CIGB for marketing and distribution of this product in the Mongolian market. (EmbaCuba Mongolia).

Relaciones Bilaterales